Your browser is no longer supported. Please, upgrade your browser.
LMNX Luminex Corporation weekly Stock Chart
LMNX [NASD]
Luminex Corporation
Index- P/E- EPS (ttm)-0.24 Insider Own2.70% Shs Outstand46.91M Perf Week4.67%
Market Cap1.26B Forward P/E102.32 EPS next Y0.26 Insider Trans4.16% Shs Float42.81M Perf Month14.05%
Income-10.40M PEG- EPS next Q-0.03 Inst Own85.10% Short Float4.14% Perf Quarter16.09%
Sales334.60M P/S3.77 EPS this Y-190.70% Inst Trans1.07% Short Ratio4.45 Perf Half Y24.01%
Book/sh10.50 P/B2.56 EPS next Y353.45% ROA-0.70% Target Price24.00 Perf Year16.49%
Cash/sh1.26 P/C21.32 EPS next 5Y15.00% ROE-0.80% 52W Range17.34 - 29.54 Perf YTD16.19%
Dividend0.36 P/FCF- EPS past 5Y-17.60% ROI-2.80% 52W High-8.90% Beta0.42
Dividend %1.34% Quick Ratio2.20 Sales past 5Y8.10% Gross Margin54.60% 52W Low55.15% ATR2.30
Employees1247 Current Ratio3.50 Sales Q/Q11.60% Oper. Margin-3.60% RSI (14)54.28 Volatility10.82% 9.55%
OptionableYes Debt/Eq0.00 EPS Q/Q47.70% Profit Margin-1.10% Rel Volume2.81 Prev Close27.08
ShortableYes LT Debt/Eq0.00 EarningsFeb 10 AMC Payout- Avg Volume398.21K Price26.91
Recom2.70 SMA201.57% SMA509.14% SMA20023.23% Volume1,120,796 Change-0.63%
Sep-27-19Downgrade JP Morgan Neutral → Underweight $23 → $21
Jan-05-18Initiated BTIG Research Buy $24
Jan-18-17Initiated Deutsche Bank Sell $18
Oct-12-16Initiated Avondale Mkt Outperform $27
Aug-18-16Upgrade JP Morgan Underweight → Neutral
Aug-04-15Upgrade Wedbush Neutral → Outperform
Nov-05-13Reiterated UBS Neutral $24 → $21.50
Jul-30-13Downgrade UBS Buy → Neutral $22 → $24
Aug-23-12Upgrade UBS Neutral → Buy $25 → $22
Jul-31-12Downgrade William Blair Outperform → Mkt Perform
May-01-12Reiterated UBS Neutral $22 → $25
Mar-12-10Initiated Jefferies & Co Buy $20
Nov-18-09Initiated William Blair Mkt Perform
May-08-09Reiterated Wedbush Morgan Buy $26 → $28
Apr-14-09Initiated Piper Jaffray Neutral
Dec-12-08Downgrade Leerink Swann Outperform → Mkt Perform
Oct-16-08Initiated UBS Neutral
Oct-10-08Initiated Cowen & Co Neutral
Aug-08-08Reiterated Canaccord Adams Buy $24 → $26
Jul-15-08Reiterated Canaccord Adams Buy $22 → $24
Mar-27-20 04:05PM  Luminex Receives FDA Emergency Use Authorization for NxTAG® CoV Extended Panel to Detect the SARS-CoV-2 Virus that Causes COVID-19 Disease PR Newswire
07:45AM  Is Luminex Corporation's (NASDAQ:LMNX) CEO Paid At A Competitive Rate? Simply Wall St.
Mar-17-20 09:02AM  Austin companies at forefront of race to boost coronavirus testing American City Business Journals +9.90%
Mar-13-20 07:30AM  Luminex Provides Update on SARS-CoV-2 Validation Testing Efforts PR Newswire +15.29%
Mar-11-20 11:30AM  Luminex (LMNX) Up 13.2% Since Last Earnings Report: Can It Continue? Zacks
Mar-04-20 09:33AM  Luminex Hits a New 52-Week High: What's Driving the Stock? Zacks
07:30AM  Luminex Provides Updates on Critical Efforts Related to Novel Coronavirus PR Newswire
Mar-02-20 08:27AM  Luminex Files for FDA 510(k) Clearance of RSP Flex Assay Zacks +6.46%
Mar-01-20 09:00PM  Luminex Corporation Submits VERIGENE(R) II Respiratory Flex Assay for FDA Clearance PR Newswire
Feb-24-20 09:00AM  Luminex Corporation Submits VERIGENE® II Respiratory Flex Assay for FDA Clearance PR Newswire
Feb-18-20 11:57AM  Luminex Corporation Declares First Quarter Cash Dividend PR Newswire
Feb-17-20 05:31AM  Edited Transcript of LMNX earnings conference call or presentation 10-Feb-20 10:00pm GMT Thomson Reuters StreetEvents
Feb-13-20 03:10PM  Luminex Corporation to Participate At Upcoming Healthcare Investor Conferences in March 2020 PR Newswire
Feb-11-20 09:58AM  Luminex (LMNX) Earnings and Revenues Beat Estimates in Q4 Zacks
07:30AM  Does This Valuation Of Luminex Corporation (NASDAQ:LMNX) Imply Investors Are Overpaying? Simply Wall St.
Feb-10-20 04:03PM  Luminex Corporation Reports Fourth Quarter and Full-Year 2019 Results PR Newswire
03:00PM  Luminex Corp. to Host Earnings Call ACCESSWIRE
Feb-03-20 12:30PM  Analysts Estimate Luminex (LMNX) to Report a Decline in Earnings: What to Look Out for Zacks
Jan-23-20 09:02AM  Luminex Corporation To Release Fourth Quarter and Full-Year 2019 Results After Market Close On February 10, 2020 PR Newswire
Jan-13-20 09:44AM  Is Now The Time To Look At Buying Luminex Corporation (NASDAQ:LMNX)? Simply Wall St.
Jan-12-20 05:00PM  Luminex Corporation Announces 2019 Highlights and 2020 Guidance; Company to Present at 38th Annual J.P. Morgan Healthcare Conference PR Newswire
Jan-02-20 11:23AM  A Trio of High-Quality Stocks GuruFocus.com
Dec-13-19 07:03AM  Looking For Steady Income For Your Dividend Portfolio? Is Luminex Corporation (NASDAQ:LMNX) A Good Fit? Simply Wall St.
Dec-06-19 12:20PM  Luminex Corporation Declares Fourth Quarter Cash Dividend PR Newswire
Dec-04-19 11:30AM  Luminex (LMNX) Up 13.4% Since Last Earnings Report: Can It Continue? Zacks
Nov-25-19 09:00AM  Luminex Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference on December 4, 2019 PR Newswire
Nov-14-19 07:19AM  Edited Transcript of LMNX earnings conference call or presentation 4-Nov-19 10:00pm GMT Thomson Reuters StreetEvents
Nov-11-19 06:22AM  The Independent Chairman of Luminex Corporation (NASDAQ:LMNX), George Loewenbaum, Just Bought 4.3% More Shares Simply Wall St. +5.04%
Nov-05-19 10:41AM  Luminex (LMNX) Reports Q3 Loss, Misses Revenue Estimates Zacks -7.37%
Nov-04-19 03:46PM  Luminex Corporation Reports Third Quarter 2019 Results and Submission of VERIGENE II Gastrointestinal Flex Assay to the FDA PR Newswire -8.43%
12:25PM  Does The Luminex Corporation (NASDAQ:LMNX) Share Price Tend To Follow The Market? Simply Wall St.
Oct-28-19 12:39PM  Is Luminex Corporation (LMNX) A Good Stock To Buy ? Insider Monkey
Oct-25-19 03:43PM  Luminex Corporation To Release Third Quarter 2019 Results After Market Close On November 4, 2019 PR Newswire
Oct-04-19 10:03AM  Is Luminex Corporation's (NASDAQ:LMNX) CEO Salary Justified? Simply Wall St.
Oct-03-19 10:58AM  Luminex Gets FDA Nod for ARIES MRSA Assay, Boosts Platform Zacks
Oct-01-19 09:05AM  Luminex Receives FDA 510(k) Clearance for the ARIES® MRSA Assay PR Newswire
Sep-26-19 12:28PM  Luminex Corporation to Present at the Cantor Global Healthcare Conference on October 2, 2019 PR Newswire
Sep-04-19 07:26AM  Do Insiders Own Lots Of Shares In Luminex Corporation (NASDAQ:LMNX)? Simply Wall St.
Sep-03-19 08:00AM  Luminex Corporation to Present at the Morgan Stanley 17th Annual Global Healthcare Conference PR Newswire
Aug-27-19 05:15PM  Luminex Corp (LMNX) President & CEO Nachum Shamir Bought $98,550 of Shares GuruFocus.com
Aug-05-19 10:09AM  Edited Transcript of LMNX earnings conference call or presentation 31-Jul-19 8:30pm GMT Thomson Reuters StreetEvents -6.41%
Aug-01-19 10:42AM  Luminex (LMNX) Reports Q2 Loss, Beats Revenue Estimates Zacks
Jul-31-19 10:24PM  Luminex Corp (DE) (LMNX) Q2 2019 Earnings Call Transcript Motley Fool
04:01PM  Luminex Corporation Reports Second Quarter 2019 Financial Results And Increase In Quarterly Dividend PR Newswire
Jul-26-19 12:18PM  If You Had Bought Luminex (NASDAQ:LMNX) Stock A Year Ago, You'd Be Sitting On A 39% Loss, Today Simply Wall St.
Jul-24-19 10:32AM  Earnings Preview: Luminex (LMNX) Q2 Earnings Expected to Decline Zacks
Jul-11-19 12:34PM  Luminex Corporation Second Quarter Earnings Release Scheduled for July 31, 2019 PR Newswire
Jul-03-19 09:41AM  Luminex (LMNX) Presents ARIES MRSA Assay to FDA for Clearance Zacks
Jul-01-19 04:31PM  Luminex Submits ARIES MRSA Assay for FDA Clearance PR Newswire
Jun-11-19 10:48AM  Is Luminex Corporation's (NASDAQ:LMNX) 1.7% ROE Worse Than Average? Simply Wall St.
Jun-05-19 09:30AM  Why Is Luminex (LMNX) Down 3.1% Since Last Earnings Report? Zacks
May-31-19 08:31AM  Luminex xMAP Picked by EDP Biotech to Boost Cancer Diagnostics Zacks
May-28-19 07:07AM  EDP Biotech to Develop and Market Colorectal Cancer Early Detection Blood Test Using Luminex xMAP® Technology PR Newswire
May-27-19 11:25AM  Edited Transcript of LMNX earnings conference call or presentation 6-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-21-19 02:38PM  Luminex Corporation Declares Second Quarter Cash Dividend PR Newswire
May-14-19 08:00AM  Luminex Corporation to Present at Upcoming Healthcare Investor Conferences PR Newswire
May-07-19 06:05AM  Luminex (LMNX) Reports Q1 Loss, Misses Revenue Estimates Zacks -7.96%
May-06-19 10:23PM  Luminex Corp (LMNX) Q1 2019 Earnings Call Transcript Motley Fool
05:55PM  Luminex (LMNX) Reports Q1 Loss, Misses Revenue Estimates Zacks
04:49PM  Luminex: 1Q Earnings Snapshot Associated Press
04:01PM  Luminex Corporation Reports First Quarter 2019 Financial Results PR Newswire
09:19AM  Q1 Earnings Outlook For Luminex Benzinga
May-02-19 01:56PM  Is Luminex Corporation (LMNX) A Good Stock To Buy? Insider Monkey
May-01-19 03:53PM  Should You Be Tempted To Sell Luminex Corporation (NASDAQ:LMNX) Because Of Its P/E Ratio? Simply Wall St.
Apr-29-19 10:31AM  Analysts Estimate Luminex (LMNX) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-18-19 10:37AM  Luminex Corporation First Quarter Earnings Release Scheduled for May 6, 2019 PR Newswire
Mar-28-19 10:42AM  Can Retail Pharmacy USA Lift Walgreens' (WBA) Q2 Earnings? Zacks
Mar-26-19 03:27PM  Should Luminex Corporation (NASDAQ:LMNX) Be Part Of Your Income Portfolio? Simply Wall St.
Mar-06-19 09:30AM  Luminex (LMNX) Down 2.7% Since Last Earnings Report: Can It Rebound? Zacks
Mar-05-19 10:55AM  Luminex Corporation to Present at the Barclays Global Healthcare Conference PR Newswire
Feb-26-19 01:48PM  Luminex Corp (LMNX) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
Feb-25-19 08:52AM  In the money Feb. 25: $35M in deals reported, including pair of contracts for military American City Business Journals
Feb-21-19 07:16AM  Luminex Hurt By Segmental Sluggishness, Stiff Competition Zacks
Feb-20-19 10:46AM  Should You Be Concerned About Luminex Corporations (NASDAQ:LMNX) Historical Volatility? Simply Wall St.
Feb-19-19 07:30AM  Market Trends Toward New Normal in salesforce.com, inc, Genpact, Luminex, Rush Enterprises, Kimball International, and Jones Lang LaSalle Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
01:01AM  MDxHealth (R): MDxHealth Appoints Michael K. McGarrity as CEO GlobeNewswire
Feb-08-19 02:52PM  Luminex Corporation Declares First Quarter Cash Dividend PR Newswire
Feb-06-19 08:11AM  Luminex (LMNX) Q4 Earnings Miss, 2019 Guidance Lacks Luster Zacks -7.44%
Feb-05-19 09:14PM  Edited Transcript of LMNX earnings conference call or presentation 4-Feb-19 9:30pm GMT Thomson Reuters StreetEvents -9.27%
Feb-04-19 08:50PM  Luminex Corp (LMNX) Q4 2018 Earnings Conference Call Transcript Motley Fool
06:25PM  Luminex (LMNX) Q4 Earnings Miss Estimates Zacks
05:29PM  Luminex: 4Q Earnings Snapshot Associated Press
04:21PM  Luminex Corporation Reports Fourth Quarter and Full-Year 2018 Financial Results PR Newswire
Jan-28-19 10:30AM  Earnings Preview: Luminex (LMNX) Q4 Earnings Expected to Decline Zacks
Jan-23-19 02:34PM  Who Has Been Selling Luminex Corporation (NASDAQ:LMNX) Shares? Simply Wall St.
Jan-09-19 06:55AM  Luminex's (LMNX) Preliminary Q4 Results Cheer Investors Zacks
Jan-07-19 10:03AM  Here's Why Investors Should Hold Luminex (LMNX) Stock Now Zacks
08:00AM  Luminex Announces Preliminary Revenue for the Fourth Quarter and Full Year 2018; Company to Present at 37th Annual J.P. Morgan Healthcare Conference PR Newswire
Jan-04-19 08:27AM  LMNX or PACB: Which is a Better MedTech Investment Pick? Zacks
Jan-03-19 09:10AM  Luminex Buys MilliporeSigma's Flow Cytometry Unit for $75M Zacks
Jan-02-19 09:09AM  Austin's top-performing stocks of 2018 American City Business Journals
08:00AM  Luminex Corporation Completes Acquisition of MilliporeSigma's Flow Cytometry Portfolio PR Newswire
Dec-18-18 02:20PM  How Financially Strong Is Luminex Corporation (NASDAQ:LMNX)? Simply Wall St.
Dec-11-18 01:46PM  Luminex Corporation Declares Fourth Quarter Cash Dividend PR Newswire
07:30AM  Report: Exploring Fundamental Drivers Behind Sabre, Catalyst Pharmaceuticals, Renewable Energy Group, Luminex, Parker Drilling, and Apollo Endosurgery New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Dec-05-18 09:30AM  Why Is Luminex (LMNX) Up 12.4% Since Last Earnings Report? Zacks
Nov-12-18 12:52PM  Luminex Corporation (NASDAQ:LMNX) Delivered A Weaker ROE Than Its Industry Simply Wall St.
Nov-08-18 03:53AM  Edited Transcript of LMNX earnings conference call or presentation 5-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Nov-07-18 11:27AM  Luminex's (LMNX) Q3 Earnings and Revenues Miss Estimates Zacks +6.62%
Nov-05-18 10:44PM  Luminex Corporation (LMNX) Q3 Earnings Conference Call Transcript Motley Fool
Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; ARIES system, a sample to answer real-time PCR platform; ARIES M1 system, a single-module version of the ARIES System; and VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market. The company also provides MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; SYNCT data management software solutions; TDAS, an analysis program designed for development and optimization of nucleic acid assays; IDEAS, an image analysis software; and xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism. In addition, it offers MultiCode assays and products comprising HSV 1&2 assays, and other products to detect infectious agents in clinical samples; ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 assays, ARIES FLU A/B and RSV assays, ARIES group A strep assays, ARIES bordetella assays, ARIES GBS assay, and ARIES C. difficile assays; and VERIGENE test cartridges, as well as operates as an original equipment manufacturer of custom reagents and instrumentation. The company serves pharmaceutical companies, clinical laboratories, and research and medical institutions. Luminex Corporation was founded in 1995 and is based in Austin, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CURRIE HARRISS TSVP, Finance & CFOMar 09Option Exercise16.5511,217185,641222,913Mar 10 05:09 PM
Myers RandallSVP, Global Mfg and QualityFeb 27Option Exercise16.0610,000160,60035,142Feb 28 12:16 PM
Myers RandallSVP, Global Mfg and QualityFeb 27Sale23.6610,000236,56525,142Feb 28 12:16 PM
Myers RandallSVP, Global Mfg and QualityFeb 24Option Exercise16.067,702123,69432,844Feb 25 05:38 PM
Myers RandallSVP, Global Mfg and QualityFeb 24Sale23.317,702179,56125,142Feb 25 05:38 PM
Myers RandallSVP, Global Mfg and QualityFeb 20Option Exercise16.061,45723,39925,527Feb 21 10:35 AM
Collins Charles J.SR VP, R&D - USFeb 20Sale23.536,090143,29727,203Feb 21 10:42 AM
Myers RandallSVP, Global Mfg and QualityFeb 20Sale23.901,45734,82225,142Feb 21 10:35 AM
Myers RandallSVP, Global Mfg and QualityFeb 19Option Exercise16.0615,841254,40639,911Feb 21 10:35 AM
Myers RandallSVP, Global Mfg and QualityFeb 19Sale23.8615,841377,96224,070Feb 21 10:35 AM
LOEWENBAUM G WALTER IIDirectorNov 18Buy19.802,95558,509584,551Nov 20 11:40 AM
LOEWENBAUM G WALTER IIDirectorNov 14Buy19.792,04540,469581,596Nov 15 05:47 PM
SHAMIR NACHUMPresident & CEONov 11Buy19.305,00096,482197,534Nov 12 12:23 PM
LOEWENBAUM G WALTER IIDirectorNov 08Buy18.1436,657664,841579,551Nov 08 05:33 PM
LOEWENBAUM G WALTER IIDirectorNov 07Buy17.8845,000804,591542,894Nov 08 05:33 PM
SHAMIR NACHUMPresident & CEOAug 26Buy19.715,00098,528192,534Aug 27 03:27 PM